Elisabeth Oelmann
Chief Tech/Sci/R&D Officer bij NUCANA PLC
Actieve functies van Elisabeth Oelmann
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| NUCANA PLC | Chief Tech/Sci/R&D Officer | 01-09-2020 | - |
Loopbaan van Elisabeth Oelmann
Eerdere bekende functies van Elisabeth Oelmann
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
PRA International LLC
 PRA International LLC Pharmaceuticals: OtherHealth Technology Part of ICON plc, PRA International LLC is a clinical research organization. The private company is based in Raleigh, NC. | Corporate Officer/Principal | - | - |
| Freie Universität Berlin | Corporate Officer/Principal | - | - |
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Chief Tech/Sci/R&D Officer | - | - |
Opleiding van Elisabeth Oelmann
| University of Münster | Doctorate Degree |
Statistieken
Internationaal
| Duitsland | 3 |
| Verenigd Koninkrijk | 3 |
| Verenigde Staten | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| NUCANA PLC | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
PRA International LLC
PRA International LLC Pharmaceuticals: OtherHealth Technology Part of ICON plc, PRA International LLC is a clinical research organization. The private company is based in Raleigh, NC. | Health Technology |
- Beurs
- Insiders
- Elisabeth Oelmann
- Ervaring
